About Paul Denslow
Paul Denslow is CEO and director at Intus Biosciences.
Paul Denslow first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Denslow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Denslow works with at each company, as listed on that company's latest Form D.
Intus Biosciences, LLC · Form D, May 27, 2025
DG
Donna Galluzzo
Director
FM
Frank Marco
Director
AM
Alan Mendelson
Director
DW
Daniel Wagner
Director
MD
Mark Driscoll
Director